The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
Luca Mazzarella(Centro Cardiologico Monzino), Giuseppe Curigliano(European Institute of Oncology), Dario Trapani(Harvard University), Emanuela Ferraro(University of Milan), Paolo D’Amico(Ripamonti), Giulia Viale(Istituti di Ricovero e Cura a Carattere Scientifico), Bruno A. Duso(Inserm), Carmen Belli(European Institute of Oncology)
Cited by 99
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k